For instance, compared with non-Hispanic white Americans, AA women diagnosed with TNBC had a higher tumor grade (65 vs. 43%), a more increased proliferation marker (KI67 > 10%, 88% vs. 54%), a higher inflammatory cytokine (IL-6, 4.5% vs. 0.88%), and a higher genetic mutation (TP53 46% vs. 27%; histone-lysine N-methyltransferase-MLL3 12% vs. 6%) [10]. The gene discussed is TP53; the disease is neoplasm.